240 related articles for article (PubMed ID: 16048497)
1. Two rare mutations in Turkey: IVS I.130(G-C) and IVS II.848(C-A).
Nal N; Manguoglu AE; Sargin CF; Keser I; Kupesiz A; Yesilipek A; Luleci G
Clin Lab Haematol; 2005 Aug; 27(4):274-7. PubMed ID: 16048497
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
Darwish HM; El-Khatib FF; Ayesh S
Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
[TBL] [Abstract][Full Text] [Related]
3. combination of IVS2.849 A-G witH IVS1.1 G-A: a mutation of beta-globin gene in a Turkish beta-thalessemia major patient.
Manguoğlu E; Sargin CF; Nal N; Keser I; Küpesiz A; Yeşilipek A; Lüleci G
Pediatr Hematol Oncol; 2005 Jun; 22(4):291-5. PubMed ID: 16020116
[TBL] [Abstract][Full Text] [Related]
4. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
[TBL] [Abstract][Full Text] [Related]
5. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
Basak AN
Hemoglobin; 2007; 31(2):233-41. PubMed ID: 17486506
[TBL] [Abstract][Full Text] [Related]
6. THE Hb S/beta+ -thalassemia phenotype demonstrates that the IVS-I (-2) (A>C) mutation is a mild beta-thalassemia allele.
Schmugge M; Waye JS; Basran RK; Zurbriggen K; Frischknecht H
Hemoglobin; 2008; 32(3):303-7. PubMed ID: 18473247
[TBL] [Abstract][Full Text] [Related]
7. Study of beta-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients.
El-Gawhary S; El-Shafie S; Niazi M; Aziz M; El-Beshlawy A
Hemoglobin; 2007; 31(1):63-9. PubMed ID: 17365006
[TBL] [Abstract][Full Text] [Related]
8. Identification of three novel mutations [-41 (A>C), codon 24 (-G), and IVS-I-109 (-T)], in a study of beta-thalassemia alleles in the Isfahan region of Iran.
Salehi R; Fisher CA; Bignell PA; Eslami G; Old JM
Hemoglobin; 2010; 34(1):115-20. PubMed ID: 20113296
[TBL] [Abstract][Full Text] [Related]
9. Distribution of beta-thalassemia mutations in the northern provinces of Iran.
Derakhshandeh-Peykar P; Akhavan-Niaki H; Tamaddoni A; Ghawidel-Parsa S; Naieni KH; Rahmani M; Babrzadeh F; Dilmaghani-Zadeh M; Farhud DD
Hemoglobin; 2007; 31(3):351-6. PubMed ID: 17654072
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of beta-thalassemia mutations in Guadeloupe.
Romana M; Keclard L; Guillemin G; Lavocat E; Saint-Martin C; Berchel C; Mérault G
Am J Hematol; 1996 Dec; 53(4):228-33. PubMed ID: 8948659
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of beta-thalassemia and sickle cell anemia in Antalya.
Keser I; Sanlioglu AD; Manguoglu E; Guzeloglu Kayisli O; Nal N; Sargin F; Yesilipek A; Simsek M; Mendilcioglu I; Canatan D; Luleci G
Acta Haematol; 2004; 111(4):205-10. PubMed ID: 15153712
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of beta-Thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control.
Hussein G; Fawzy M; Serafi TE; Ismail EF; Metwally DE; Saber MA; Giansily M; Schved JF; Pissard S; Martinez PA
Hemoglobin; 2007; 31(1):49-62. PubMed ID: 17365005
[TBL] [Abstract][Full Text] [Related]
13. First Spanish case of thalassemia major due to a compound heterozygosity for the IVS-II-848 (C --> A) and codon 39 (C --> T) mutations of the beta-globin gene.
Ropero P; Villegas A; Muñoz J; Briceño O; Mora A; Salvador M; Polo M; González FA
Hemoglobin; 2006; 30(1):15-21. PubMed ID: 16540410
[TBL] [Abstract][Full Text] [Related]
14. The molecular analysis of beta-thalassemia mutations in Lorestan Province, Iran.
Kiani AA; Mortazavi Y; Zeinali S; Shirkhani Y
Hemoglobin; 2007; 31(3):343-9. PubMed ID: 17654071
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of beta-thalassemia in the Dohuk region of Iraq.
Al-Allawi NA; Jubrael JM; Hughson M
Hemoglobin; 2006; 30(4):479-86. PubMed ID: 16987803
[TBL] [Abstract][Full Text] [Related]
16. Variable clinical severity of Hb E beta-thalassemia among Indians.
Nadkarni A; Ghosh K; Gorakshakar A; Colah R; Mohanty D
J Assoc Physicians India; 1999 Oct; 47(10):966-8. PubMed ID: 10778688
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of Greek nondeletional hereditary persistence of fetal hemoglobin and beta-thalassemia compound heterozygotes.
Papadakis MN; Patrinos GP; Tsaftaridis P; Loutradi-Anagnostou A
J Mol Med (Berl); 2002 Apr; 80(4):243-7. PubMed ID: 11976733
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of patients with beta-thalassemia major in central Taiwan by amplified created restriction site analysis.
Peng CT; Wu JY; Tsai CH; Tsai FJ; Chang JG
J Hum Genet; 1998; 43(4):237-41. PubMed ID: 9852674
[TBL] [Abstract][Full Text] [Related]
19. High incidence of the CD8/9 (+G) beta 0-thalassemia mutation in Spain.
Villegas A; Ropero P; Ataulfo González F; Martí E; Anguita E; de Blas JM
Haematologica; 1998 Dec; 83(12):1066-8. PubMed ID: 9949622
[TBL] [Abstract][Full Text] [Related]
20. Observation of a rare hemoglobin variant [Hb Lulu island, beta107(G9)Gly-->Asp, GGC-->GAC] co-inherited with a beta+-thalassemia mutation [IVS-I-110 (G-->A)] or in the heterozygous state in a Greek-Albanian family.
Papassotiriou I; Stamoulakatou A; Wajcman H; Kister J; Dimisianos G; Lazaropoulou C; Kanavaki I; Vavourakis E; Kattamis A; Kanavakis E; Traeger-Synodinos J
Hemoglobin; 2006; 30(4):409-18. PubMed ID: 16987796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
